• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.嵌合抗原受体（CAR）T细胞和T细胞衔接器毒性及疗效生物标志物的发现蓝图。
Blood Adv. 2021 Jun 8;5(11):2519-2522. doi: 10.1182/bloodadvances.2021004604.
2
Immunophenotypic Analysis of CAR-T Cells.嵌合抗原受体T细胞（CAR-T细胞）的免疫表型分析
Methods Mol Biol. 2020;2086:195-201. doi: 10.1007/978-1-0716-0146-4_14.
3
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.嵌合抗原受体 T 细胞疗法治疗癌症：以基础研究为导向的观点。
Immunotherapy. 2018 Mar;10(3):221-234. doi: 10.2217/imt-2017-0133.
4
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy.嵌合抗原受体工程化T细胞用于癌症免疫治疗的新见解。
J Hematol Oncol. 2017 Jan 3;10(1):1. doi: 10.1186/s13045-016-0379-6.
5
Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer.嵌合抗原受体修饰的 T 细胞针对上皮细胞黏附分子治疗结直肠癌的临床前评估。
Hum Gene Ther. 2019 Apr;30(4):402-412. doi: 10.1089/hum.2018.229. Epub 2019 Mar 13.
6
Analysis of Antitumor Effects of CAR-T Cells in Mice with Solid Tumors.嵌合抗原受体T细胞（CAR-T）对实体瘤小鼠的抗肿瘤作用分析
Methods Mol Biol. 2020;2086:251-271. doi: 10.1007/978-1-0716-0146-4_19.
7
Advances and challenges in CAR-T cell-mediated immunotherapy.嵌合抗原受体T细胞介导的免疫疗法的进展与挑战。
Int Rev Immunol. 2022;41(6):565-566. doi: 10.1080/08830185.2022.2111107.
8
Phenotyping of CAR T cells.CAR T 细胞表型分析。
Methods Cell Biol. 2022;167:71-80. doi: 10.1016/bs.mcb.2021.10.001. Epub 2021 Nov 10.
9
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.社区肿瘤学家的嵌合抗原受体T细胞疗法
Oncologist. 2016 May;21(5):608-17. doi: 10.1634/theoncologist.2015-0421. Epub 2016 Mar 23.
10
Nano-optogenetic CAR-T Cell Immunotherapy.纳米光遗传学嵌合抗原受体T细胞免疫疗法
Methods Mol Biol. 2024;2748:267-278. doi: 10.1007/978-1-0716-3593-3_17.

引用本文的文献

1
CAR T-cell detection scoping review: an essential biomarker in critical need of standardization.嵌合抗原受体 T 细胞检测范围综述：一种急需标准化的重要生物标志物。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006596.
2
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.嵌合抗原受体 T 细胞 CD19 在二线大 B 细胞淋巴瘤中的作用：来自 3 期临床试验的经验教训。美国移植和细胞治疗学会专家小组意见。
Transplant Cell Ther. 2022 Sep;28(9):546-559. doi: 10.1016/j.jtct.2022.06.019. Epub 2022 Jun 26.
3
Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.接受免疫效应细胞治疗或造血细胞移植的儿科患者的细胞因子释放综合征及相关急性毒性
Front Oncol. 2022 Mar 24;12:841117. doi: 10.3389/fonc.2022.841117. eCollection 2022.
4
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential.嵌合抗原受体 T 细胞疗法的多重分析概述：见解与潜能。
Expert Rev Proteomics. 2021 Sep;18(9):767-780. doi: 10.1080/14789450.2021.1992276. Epub 2021 Oct 17.

本文引用的文献

1
Isabl Platform, a digital biobank for processing multimodal patient data.Isabl 平台，用于处理多模态患者数据的数字生物库。
BMC Bioinformatics. 2020 Nov 30;21(1):549. doi: 10.1186/s12859-020-03879-7.
2
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer.癌症登月计划免疫肿瘤转化网络（IOTN）：加速基础发现向改善癌症免疫治疗和免疫预防的临床转化。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000796.
3
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.嵌合抗原受体 T 细胞疗法在复发/难治性侵袭性 B 细胞非霍奇金淋巴瘤临床实践中的应用：来自美国移植和细胞治疗学会的专家小组意见。
Biol Blood Marrow Transplant. 2019 Dec;25(12):2305-2321. doi: 10.1016/j.bbmt.2019.08.015. Epub 2019 Aug 22.
4
Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.临床试验中少数族裔的招募：在免疫治疗时代，老问题有了新的紧迫性。
Am Soc Clin Oncol Educ Book. 2019 Jan;39:3-10. doi: 10.1200/EDBK_100021. Epub 2019 May 17.
5
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).嵌合抗原受体T细胞（CAR-T）在B细胞急性淋巴细胞白血病（ALL）中的临床应用——欧洲血液与骨髓移植学会（EBMT）和美国血液与骨髓移植学会（ASBMT）的专家意见
Bone Marrow Transplant. 2019 Nov;54(11):1868-1880. doi: 10.1038/s41409-019-0451-2. Epub 2019 May 15.
6
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.ASTCT 细胞因子释放综合征和免疫效应细胞相关神经系统毒性的共识分级标准。
Biol Blood Marrow Transplant. 2019 Apr;25(4):625-638. doi: 10.1016/j.bbmt.2018.12.758. Epub 2018 Dec 25.
7
Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization.生物标志物鉴定：迈向生物标志物开发、监管认可及应用的多方利益相关者框架
Clin Pharmacol Ther. 2015 Jul;98(1):34-46. doi: 10.1002/cpt.136. Epub 2015 Jun 6.

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.

作者信息

Paczesny Sophie, Pasquini Marcelo C, Pavletic Steven Z, Agarwal Amit, Spellman Stephen, Kean Leslie, Bernatchez Chantale, Gust Juliane, Staedtke Verena, Perales Miguel-Angel

机构信息

Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

出版信息

Blood Adv. 2021 Jun 8;5(11):2519-2522. doi: 10.1182/bloodadvances.2021004604.

DOI:10.1182/bloodadvances.2021004604
PMID:34100901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8238483/
Abstract
摘要